SEC
CELG

Seven Eight Capital’s Celgene Corp CELG Stock Holding History

Seven Eight Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-66,760
Closed -$6.63M – 824
2019
Q3 		$6.63M Sell
66,760
-81,159
-55% -$7.71M 0.35% 80
2019
Q2 		$13.7M Buy
147,919
+3,800
+3% +$361K 0.72% 22
2019
Q1 		$13.6M Sell
144,119
-125,081
-46% -$10.9M 0.72% 32
2018
Q4 		$17.3M Buy
269,200
+236,200
+716% +$17.4M 0.97% 14
2018
Q3 		$2.95M Sell
33,000
-149,600
-82% -$13.2M 0.18% 174
2018
Q2 		$14.5M Buy
182,600
+116,900
+178% +$9.71M 1.01% 3
2018
Q1 		$5.86M Buy
+65,700
New +$6.31M 0.48% 82
2016
Q4 		– Sell
-28,000
Closed -$2.93M – 692
2016
Q3 		$2.93M Sell
28,000
-2,200
-7% -$238K 0.86% 23
2016
Q2 		$2.98M Buy
30,200
+13,100
+77% +$1.36M 1.02% 3
2016
Q1 		$1.71M Buy
17,100
+15,700
+1,121% +$1.62M 0.73% 24
2015
Q4 		$168K Buy
+1,400
New +$162K 0.11% 259
2015
Q2 		– Sell
-1,400
Closed -$161K – 775
2015
Q1 		$161K Buy
1,400
+600
+75% +$71.7K 0.27% 130
2014
Q4 		$89K Buy
+800
New +$84.4K 0.15% 204
2014
Q1 		– Sell
-800
Closed -$68K – 663
2013
Q4 		$68K Buy
+800
New +$63.3K 0.08% 349

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Seven Eight Capital's CELG Position: Q4 2019 in Review

Seven Eight Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 66,760 shares — an estimated $6.63M sold.

Seven Eight Capital first reported a position in CELG in Q4 2013 and held it in 14 quarters. The position peaked at $17.3M in Q4 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Seven Eight Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Seven Eight Capital sold 66,760 Celgene Corp shares in Q4 2019, an estimated $6.63M.
  • Seven Eight Capital first reported a position in Celgene Corp in Q4 2013 and held it in 14 quarters.
  • Seven Eight Capital's Celgene Corp position peaked at $17.3M in Q4 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Seven Eight Capital's 13F filing for Q4 2019, filed 13 Feb 2020.